BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 965 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,782,158 | -21.4% | 113,069 | +0.4% | 0.04% | -28.3% |
Q1 2024 | $4,814,490 | +108310.0% | 112,646 | -1.9% | 0.05% | -1.9% |
Q4 2023 | $4,441 | -99.9% | 114,871 | 0.0% | 0.05% | -5.3% |
Q3 2023 | $4,335,232 | -12.5% | 114,871 | +5.7% | 0.06% | -12.3% |
Q2 2023 | $4,953,147 | +8.5% | 108,717 | -3.4% | 0.06% | -5.8% |
Q1 2023 | $4,565,515 | -16.1% | 112,562 | +5.4% | 0.07% | -24.2% |
Q4 2022 | $5,444,564 | +12.0% | 106,819 | +18.3% | 0.09% | +3.4% |
Q3 2022 | $4,863,000 | -14.3% | 90,282 | +2.2% | 0.09% | -11.1% |
Q2 2022 | $5,672,000 | -13.8% | 88,309 | +4.1% | 0.10% | -2.9% |
Q1 2022 | $6,578,000 | +13.3% | 84,836 | +25.4% | 0.10% | -3.8% |
Q4 2021 | $5,805,000 | +7.3% | 67,630 | +0.6% | 0.11% | -5.4% |
Q3 2021 | $5,408,000 | -0.6% | 67,243 | -0.6% | 0.11% | +0.9% |
Q2 2021 | $5,443,000 | +12.5% | 67,618 | +17.9% | 0.11% | -14.0% |
Q1 2021 | $4,839,000 | +23.3% | 57,376 | +17.4% | 0.13% | +3.2% |
Q4 2020 | $3,923,000 | +16.7% | 48,893 | +17.0% | 0.12% | -11.3% |
Q3 2020 | $3,361,000 | +6.3% | 41,792 | +13.8% | 0.14% | -13.5% |
Q2 2020 | $3,161,000 | -19.3% | 36,712 | -22.9% | 0.16% | -6.9% |
Q1 2020 | $3,916,000 | -5.1% | 47,643 | -3.5% | 0.18% | +19.9% |
Q4 2019 | $4,128,000 | -9.2% | 49,362 | -5.0% | 0.15% | -13.1% |
Q3 2019 | $4,545,000 | +64.4% | 51,960 | +53.9% | 0.17% | +7.0% |
Q2 2019 | $2,765,000 | +0.7% | 33,766 | 0.0% | 0.16% | -10.8% |
Q1 2019 | $2,746,000 | +42.6% | 33,766 | +15.4% | 0.18% | +12.8% |
Q4 2018 | $1,926,000 | -6.2% | 29,262 | +9.9% | 0.16% | 0.0% |
Q3 2018 | $2,053,000 | +20.3% | 26,637 | +15.2% | 0.16% | -3.1% |
Q2 2018 | $1,707,000 | +73.1% | 23,119 | +52.5% | 0.16% | +13.4% |
Q1 2018 | $986,000 | +11.9% | 15,161 | +11.3% | 0.14% | +2.2% |
Q4 2017 | $881,000 | +1.1% | 13,627 | -1.8% | 0.14% | -5.4% |
Q3 2017 | $871,000 | +4.8% | 13,873 | +1.1% | 0.15% | -2.0% |
Q2 2017 | $831,000 | +53.0% | 13,720 | +31.1% | 0.15% | +9.5% |
Q1 2017 | $543,000 | +79.8% | 10,466 | +53.9% | 0.14% | -3.5% |
Q4 2016 | $302,000 | – | 6,801 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |